Cardiac implantable electronic device infections: The enemy that lurks beneath the skin

Journal of Long-Term Effects of Medical Implants

Volumn 20, Issue 3, 2010, Pages 203-217

  Margey, Ronan ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Biventricular pacemaker; Cardiac resynchronization; Cardiovascular device; Endocarditis; Implantable electronic device; Implantable cardioverter defibrillator; Infection; Pacemaker; Prosthesis related infections

Indexed keywords

DEFIBRILLATORS; ELECTRONIC EQUIPMENT; HEART; IMPLANTABLE CARDIOVERTER DEFIBRILLATORS; PACEMAKERS; THERMOELECTRIC EQUIPMENT;

CARDIAC RESYNCHRONIZATION; CARDIOVASCULAR DEVICES; ENDOCARDITIS; IMPLANTABLE ELECTRONIC DEVICES; INFECTION;

ELECTRON DEVICES;

CEFAZOLIN; CEPHALOSPORIN; VANCOMYCIN; ANTIINFECTIVE AGENT;

ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC THERAPY; BACTERIAL INFECTION; CARDIAC IMPLANTABLE ELECTRONIC DEVICE; CONSERVATIVE TREATMENT; DEVICE INFECTION; DEVICE REMOVAL; DIAGNOSTIC IMAGING; HEART ASSIST DEVICE; HUMAN; INFECTION PREVENTION; INFECTION RISK; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; NONHUMAN; PATHOGENESIS; POSTOPERATIVE INFECTION; REIMPLANTATION; REVIEW; RISK FACTOR; ARTIFICIAL HEART PACEMAKER; DEFIBRILLATOR; INFECTION; MICROBIOLOGY;

ANTI-INFECTIVE AGENTS; ANTIBIOTIC PROPHYLAXIS; DEFIBRILLATORS, IMPLANTABLE; DEVICE REMOVAL; HUMANS; PACEMAKER, ARTIFICIAL; PROSTHESIS-RELATED INFECTIONS; RISK FACTORS;

EID: 79958738587     PISSN: 10506934     EISSN: None     Source Type: Journal    
DOI: 10.1615/JLongTermEffMedImplants.v20.i3.40     Document Type: Review

References (71)

1. Chardak WM, Gage AA, Greatbach W. Correction of complete heart block by a self-contained and subcutaneously implanted pacemaker. J Thorac Cardiovasc Surg. 1961;42:814-25.
2. Cazeau S, Leclercq C, Lavergne T, Walker S, Varma C, Linde C, Garrigue S, Kappenberger L, Haywood GA, Santini M, Bailleul C, Daubert JC; Multisite stimulation in cardiomyopathies (MUSTIC) study investigators. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med. 2001;344:873-80.
3. Chua JD, Wilkoff BL, Lee I, Juratli N, Longworth DL, Gordon SM. Diagnosis and management of infections involving implantable electrophysiologic cardiac devices. Ann Intern Med. 2000;133:604-8.
4. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, McNulty SE, Clapp-Channing N, Davidson-Ray LD, Fraulo ES, Fishbein DP, Luceri RM, Ip JH. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005;352:225-37.
5. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, Higgins SL, Brown MW, Andrews ML. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346:877-83.
6. Connolly SJ, Gent M, Roberts RS, Dorian P, Roy D, Sheldon RS, Mitchell LB, Green MS, Klein GJ, O'Brien B. Canadian implantable defibrillator study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation. 2000;101:1297-302.
7. Kuck KH, Cappato R, Siebels J, Ruppel R. Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg (CASH). Circulation. 2000;102:748-54.
8. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, Levine JH, Saksena S, Waldo AL, Wilber D, Brown MW, Heo M. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med. 1996;335:1933-40.
9. Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G. A randomized study of the prevention of sudden death in patients with coronary artery disease: Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med. 1999;341:1882-90.
10. Hohnloser SH, Kuck KH, Dorian P, Roberts RS, Hampton JR, Hatala R, Fain E, Gent M, Connolly SJ. Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. N Engl J Med. 2004;351:2481-8.
11. Abraham WT, Fisher WG, Smith AL, Delurgio DB, Leon AR, Loh E, Kocovic DZ, Packer M, Clavell AL, Hayes DL, Ellestad M, Trupp RJ, Underwood J, Pickering F, Truex C, McAtee P, Messenger J. Cardiac resynchronization in chronic heart failure. N Engl J Med. 2002;346:1845-53.
12. Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med. 2005;352:1539-49.
13. Young JB, Abraham WT, Smith AL, Leon AR, Lieberman R, Wilkoff B, Canby RC, Schroeder JS, Liem LB, Hall S, Wheelan K. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial. JAMA. 2003;289:2685-94.
14. Zhan C, Baine WB, Sedrakyan A, Steiner C. Cardiac device implantation in the United States from 1997 through 2004: a population-based analysis. J Gen Intern Med. 2007;23(suppl 1):13-9.
15. Voigt A, Shalaby A, Saba S. Rising rates of cardiac rhythm management device infections in the United States: 1996 through 2003. J Am Coll Cardiol. 2006;48:590-1.
16. Cabell CH, Heidenreich PA, Chu VH, Moore CM, Stryjewski ME, Corey GR, Fowler VG Jr. Increasing rates of cardiac device infections among Medicare beneficiaries: 1990-1999. Am Heart J. 2004;147:582-6.
17. Uslan DZ, Sohail MR, Friedman PA, Hayes DL, Wilson WR, Steckelberg JM, Baddour LM. Frequency of permanent pacemaker or implantable cardioverter-defibrillator infection in patients with gram negative bacteremia. Clin Infect Dis. 2006;43:731-6.
18. Cacoub P, Leprince P, Nataf P, Hausfater P, Dorent R, Wechsler B, Bors V, Pavie A, Piette JC, Gandjbakhch I. Pacemaker infective endocarditis. Am J Cardiol. 1998;82:480-4.
19. Margey R, McCann H, Blake G, Keelan T, Galvin J, Lynch M, Mahon N, Sugrue D, O'Neill J. Contemporary management of and outcomes from cardiac device related infections. Europace. 2010;12:64-70.
20. Ferguson TB Jr, Ferguson CL, Crites K, Crimmins-Reda P. The additional hospital costs generated in the management of complications of pacemaker and defibrillator implantations. J Thorac Cardiovasc Surg. 1996;111:742-51.
21. Schwartz IS, Pervez N. Bacterial endocarditis associated with a permanent transvenous cardiac pacemaker. JAMA. 1971;218:736-7.
22. Corman LC, Levison ME. Sustained bacteremia and transvenous cardiac pacemakers. JAMA. 1975;233:264-6.
23. Conklin EF, Giannelli S Jr, Nealon TF Jr. Four hundred consecutive patients with permanent transvenous pacemakers. J Thorac Cardiovasc Surg. 1975;69:1-7.
24. Bluhm G. Pacemaker infections: a clinical study with special reference to prophylactic use of some isoxazolyl penicillins. Acta Med Scand Suppl. 1985;699:1-62.
25. Arber N, Pras E, Copperman Y, Schapiro JM, Meiner V, Lossos IS, Militianu A, Hassin D, Pras E, Shai A, Moshkowitz M, Sidi Y. Pacemaker endocarditis: report of 44 cases and review of the literature. Medicine (Baltimore). 1994;73:299-305.
26. Mela T, McGovern BA, Garan H, Vlahakes GJ, Torchiana DF, Ruskin J, Galvin JM. Long-term infection rates associated with pectoral versus abdominal approach to cardioverter-defibrillator implants. Am J Cardiol. 2001;88: 750-3.
27. Voight A, Shalaby A, Saba S. Continued rise in rates of cardiovascular implantable electronic device infections in the United States: temporal trends and causative insights. PACE. 2010;33:414-9.
28. Uslan DZ, Sohail MR, St Sauver JL, Friedman PA, Hayes DL, Stoner SM, Wilson WR, Steckelberg JM, Baddour LM. Permanent pacemaker and implantable cardioverterdefibrillator infection: a population-based study. Arch Intern Med. 2007;167:669-75.
29. Klug D, Balde M, Pavin D, Hidden-Lucet F, Clementy J, Sadoul N, Rey JL, Lande G, Lazarus A, Victor J, Barnay C, Grandbastien B, Kacet S; PEOPLE Study Group. Risk factors related to infections of implanted pacemakers and cardioverter-defibrillators: results of a large prospective study. Circulation. 2007;116:1349-55.
30. Poole JE, Gleva MJ, Mela T, Chung MK, Uslan DZ, Borge R, Gottipaty V, Shinn T, Dan D, Feldman LA, Seide H, Winston SA, Gallagher JJ, Langberg JJ, Mitchell K, Holcomb R, for the REPLACE registry investigators. Complication rates associated with pacemaker or implantable cardioverter-defibrillator generator replacements and upgrade procedures: results from the REPLACE registry. Circulation. 2010;122:1553-61.
31. Sohail MR, Uslan DZ, Khan AH, Friedman PA, Hayes DL, Wilson WR, Steckelberg JM, Stoner S, Baddour LM. Management and outcome of permanent and implantable cardioverter-defibrillator infections. J Am Coll Cardiol. 2007;49:1851-9.
32. Durack DT, Lukes AS, Bright DK. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service. Am J Med. 1994;96:200-9.
33. Bloom H, Heeke B, Leon A, Mera F, Delurgio D, Beshai J, Langberg J. Renal insufficiency and the risk of infection from pacemaker or defibrillator surgery. Pacing Clin Electrophysiol. 2006;29:142-5.
34. Lekkerkerker JC, van Nieuwkoop C, Trines SA, van der Bom JG, Bernards A, van de Velde ET, Bootsma M, Zeppenfeld K, Jukema JW, Borleffs JW, Schalij MJ, van Erven L. Risk factors and time delay associated with cardiac device infections: Leiden Device Registry. Heart. 2009;95: 715-20.
35. Sohail MR, Uslan DZ, Khan AH, Friedman PA, Hayes DL, Wilson WR, Steckelberg JM, Stoner SM, Baddour LM. Risk factor analysis of permanent pacemaker infection. Clin Infect Dis. 2007;45:166-73.
36. Thal S, Moukabary T, Boyella R, Shanmugasundaram M, Pierce MK, Thai H, Goldman S. The relationship between warfarin, aspirin, and clopidogrel continuation in the periprocedural period and the incidence of hematoma formation after device implantation. PACE. 2010;33:385-8.
37. Johansen JB, Nielsen JC, Arnsbo P, Moller M, Pedersen AK, Mortensen PT. Higher incidence of pacemaker infection after replacement than after first implantation: experiences from 36,076 consecutive patients. Heart Rhythm. 2006;3(Suppl 1):S102-3.
38. Al-Khatib SM, Lucas FL, Jollis JG, Malenka DJ, Wennberg DE. The relation between patients' outcomes and the volume of cardioverter-defibrillator implantation procedures performed by physicians treating Medicare beneficiaries [published correction appears in J Am Coll Cardiol. 2005;46:1964]. J Am Coll Cardiol. 2005;46:1536-40.
39. Gould PA, Krahn AD; Canadian Heart Rhythm Society Working Group on Device Advisories. Complications associated with implantable cardioverter-defibrillator replacement in response to device advisories. JAMA. 2006;295:1907-11.
40. Chamis AL, Peterson GE, Cabell CH, Corey GR, Sorrentino RA, Greenfield RA, Ryan T, Reller LB, Fowler VG Jr. Staphylococcus aureus bacteremia in patients with permanent pacemakers or implantable cardioverter-defibrillators. Circulation. 2001;104:1029-33.
41. Uslan DZ, Dowsley TF, Sohail MR, Hayes DL, Friedman PA, Wilson WR, Steckelberg JM, Baddour LM. Cardiovascular implantable electronic device infection in patients with staphylococcus aureus bacteremia. PACE. 2010;33:407-13.
42. Viola GM, Awan LL, Darouiche RO. Nonstaphylococcal infections of cardiac implantable electronic devices. Circulation. 2010;121:2085-91.
43. Baddour LM, Epstein AE, Erickson CC, Knight BP, Levison ME, Lockhart PB, Masoudi FA, Okum EJ, Wilson WR, Beerman LB, Bolger AF, Estes NA 3rd, Gewitz M, Newburger JW, Schron EB, Taubert KA; American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee; Council on Cardiovascular Disease in Young; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Nursing; Council on Clinical Cardiology; Interdisciplinary Council on Quality of Care; American Heart Association. Update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association. Circulation. 2010;121:458-77.
44. Darouiche RO. Device-associated infections: a macroproblem that starts with microadherence. Clin Infect Dis. 2001;33:1567-72.
45. Phaller MA, Herwaldt LA. Laboratory, clinical, and epidemiological aspects of coagulase-negative staphylococci. Clin Microbiol Rev. 1988;1:281-99.
46. Veenstra GJ, Cremers FF, van Dijk H, Fleer A. Ultrastructural organization and regulation of a biomaterial adhesion of Staphylococcus epidermidis. J Bacteriol. 1996;178:537-41.
47. Wilkinson BJ. Biology. In: The Staphylococci in Human Disease. Crossley KB, Archer GL, eds. New York, NY: Churchill Livingston; 1997.
48. Heilmann C, Schweitzer O, Gerke C, Vanittanakom N, Mack D, Götz F. Molecular basis of intercellular adhesion in the biofilm-forming Staphylococcus epidermidis. Mol Microbiol. 1996;20:1083-91.
49. Vuong C, Otto M. Staphylococcus epidermidis infections. Microbes Infect. 2002;4:481-9.
50. Chua JD, Wilkoff BL, Lee I, Juratli N, Longworth DL, Gordon SM. Diagnosis and management of infections involving implantable electrophysiologic cardiac devices. Ann Intern Med. 2000;133:604-8.
51. Klug D, Lacroix D, Savoye C, Goullard L, Grandmougin D, Hennequin JL, Kacet S, Lekieffre J. Systemic infection related to endocarditis on pacemaker leads: clinical presentation and management. Circulation. 1997;95:2098-107.
52. Fowler VG Jr, Li J, Corey GR, Boley J, Marr KA, Gopal AK, Kong LK, Gottlieb G, Donovan CL, Sexton DJ, Ryan T. Role of echocardiography in evaluation of patients with Staphylococcus aureus bacteremia: experience in 103 patients. J Am Coll Cardiol. 1997;30:1072-8.
53. Lo R, D'Anca M, Cohen T, Kerwin T. Incidence and prognosis of pacemaker lead-associated masses: a study of 1,569 transesophageal echocardiograms. J Invasive Cardiol. 2006;18:599-601.
54. Vilacosta I, Sarria C, San Roman JA, Jimenez J, Castillo JA, Iturralde E, Rollan MJ, Elbal LM. Usefulness of transesophageal echocardiography for diagnosis of infected transvenous permanent pacemakers. Circulation. 1994;89:2684-7.
55. Dy Chua J, Abdul-Karim A, Mawhorter S, Procop GW, Tchou P, Niebauer M, Saliba W, Schweikert R, Wilkoff BL. The role of swab and tissue culture in the diagnosis of implantable cardiac device infection. Pacing Clin Electrophysiol. 2005;28:1276-81.
56. Mason PK, Dimarco JP, Ferguson JD, Mahapatra S, Mangrum JM, Bilchick KC, Moorman JR, Lake DE, Bergin JD. Sonication of explanted cardiac rhythm management devices for the diagnosis of pocket infections and asymptomatic bacterial colonization. PACE. 2010;33:1-7.
57. Rohacek M, Weisser M, Kobza R, Schoenenberger AW, Pfyffer GE, Erne P, Trampuz A. Bacterial colonization and infection of electrophysiological cardiac devices detected with sonication and swab culture. Circulation. 2010;121:1691-7.
58. Field ME, Jones SO, Epstein LM. How to select patients for lead extraction. Heart Rhythm. 2007;4:978-85.
59. Jones SO 4th, Eckart RE, Albert CM, Epstein LM. Large, single-center, single-operator experience with transvenous lead extraction: outcomes and changing indications. Heart Rhythm. 2008;5:520-5.
60. Smith MC, Love CJ. Extraction of transvenous pacing and ICD leads. Pacing Clin Electrophysiol. 2008;31: 736-52
61. Satsu T, Onoe M. Vacuum-assisted wound closure for pacemaker infection. PACE. 2010;33:426-30.
62. Baddour LM; Infectious Diseases Society of America's Emerging Infections Network. Long-term suppressive antimicrobial therapy for intravascular device-related infections. Am J Med Sci. 2001;322:209-12.
63. Braun MU, Rauwolf T, Bock M, Kappert U, Boscheri A, Schnabel A, Strasser RH. Percutaneous lead implantation connected to an external device in stimulation-dependent patients with systemic infection: a prospective and controlled study. PACE. 2006;29:875-9.
64. Trappe HJ, Pfitzner P, Klein H, Wenzlaff P. Infections after cardioverter-defibrillator implantation: observations in 335 patients over 10 years. Br Heart J. 1995;73:20-4.
65. Baman TS, Gupta SK, Valle JA, Yamada E. Risk factors for mortality in patients with cardiac device-related infection. Circ Arrhythm Electrophysiol. 2009;2:129-34.
66. Da Costa A, Kirkorian G, Cucherat M, Delahaye F, Chevalier P, Cerisier A, Isaaz K, Touboul P. Antibiotic prophylaxis for permanent pacemaker implantation: a meta-analysis. Circulation. 1998;97:1796-801.
67. de Oliveira JC, Martinelli M, Angelina S, Varejao T, Uipe D, Pedrosa A, Costa R, Danik S. Efficacy of antibiotic prophylaxis before the implantation of pacemakers and cardioverter-defibrillators. Results of a large, prospective randomized double-blinded placebo-controlled trial. Circulation Arrhythmia Electro. 2009;2:29-34.
68. Lakkireddy D, Valasareddi S, Ryschon K, Basarkodu K, Rovang K, Mohiuddin SM, Hee T, Schweikert R, Tchou P, Wilkoff B, Natale A, Li H. The impact of povidone-iodine pocket irrigation use on pacemaker and defibrillator infections. PACE. 2005;28:789-94.
69. Bloom HL, Constantin L, Dan D, De Lurgio DB, El-Chami M, Ganz LI, Gleed KJ, Hackett K, Kanuru NK, Lerner DJ, Rasekh A, Simons GR, Sogade FO, Sohail MR. Implantation success and infection in cardiovascular implantable electronic device procedures utilizing an antibacterial envelope. PACE. 2010;33:1-10.
70. Cohen MI, Bush DM, Gaynor JW, Vetter VL, Tanel RE, Rhodes LA. Pediatric pacemaker infections: twenty years of experience. J Thorac Cardiovasc Surg. 2002;124: 821-7.
71. Gould PA, Gula LJ, Yee R, Skanes AC, Klein GJ, Krahn AD. Cardiovascular implantable electrophysiological devicerelated infections; a review. Curr Opin Cardiol. 2010 Nov 11. [Epub ahead of print]